Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116954403 | 11695440 | 3 | F | 20110910 | 20160912 | 20151104 | 20160912 | EXP | TH-BRISTOL-MYERS SQUIBB COMPANY-16191124 | BRISTOL MYERS SQUIBB | 0.00 | DY | F | Y | 0.00000 | 20160912 | CN | GB | TH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116954403 | 11695440 | 1 | SS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Transplacental | UNK | U | 0 | CAPSULE, HARD | ||||||||
| 116954403 | 11695440 | 2 | SS | RITONAVIR. | RITONAVIR | 1 | Transplacental | U | 0 | ||||||||||
| 116954403 | 11695440 | 3 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Transplacental | UNK | U | 20972 | |||||||||
| 116954403 | 11695440 | 4 | C | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 116954403 | 11695440 | 5 | C | LAMIVUDINE. | LAMIVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 116954403 | 11695440 | 6 | C | LOPINAVIR + RITONAVIR | LOPINAVIRRITONAVIR | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116954403 | 11695440 | 1 | Product used for unknown indication |
| 116954403 | 11695440 | 2 | HIV infection |
| 116954403 | 11695440 | 3 | Product used for unknown indication |
| 116954403 | 11695440 | 4 | Product used for unknown indication |
| 116954403 | 11695440 | 5 | Product used for unknown indication |
| 116954403 | 11695440 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116954403 | 11695440 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116954403 | 11695440 | Foetal exposure during pregnancy | |
| 116954403 | 11695440 | Jaundice neonatal | |
| 116954403 | 11695440 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116954403 | 11695440 | 1 | 20110214 | 0 | ||
| 116954403 | 11695440 | 3 | 20110214 | 0 | ||
| 116954403 | 11695440 | 4 | 20110214 | 0 | ||
| 116954403 | 11695440 | 5 | 20110214 | 0 |